Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus	Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus	Active, not recruiting	Phase 3	2025-09-26		NCT04582136

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Municipal Science & Technology Commission	5
Chinese SLE Treatment And Research Group	13
North China Pharmaceutical Group Corporation	1

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
First Affiliated Hospital of Kunming Medical University	Kunming	China	7
Peking Union Medical College Hospital	Beijing	China	1
Shenzhen People's Hospital	Shenzhen	China	25
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	103
The First Hospital of China Medical University	Shenyang	China	42
The Second Affiliated Hospital of Nanchang University	Nanchang	China	32